CABALETTA BIO INC. - COMMON STOCK
1.8700
22-November-24 15:44:58
15 minutes delayed
Stocks
0.0000
0.00%
Today's range
1.8100 - 2.0100
ISIN
N/A
Source
NASDAQ
-
Cabaletta Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
05 Jan 2023 07:00:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio Announces $35 Million Offering
08 Dec 2022 06:00:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 5th Annual Evercore ISI HealthCONx Conference
22 Nov 2022 07:00:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
10 Nov 2022 06:00:02 By Nasdaq GlobeNewswire
-
11 Oct 2022 06:00:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 29th Annual Congress of the European Society of Gene & Cell Therapy
06 Oct 2022 07:00:02 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the Chardan 6th Annual Genetic Medicines Conference
26 Sep 2022 07:00:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio Presents New Interim Data from the DesCAARTes™ Phase 1 Trial at the 31st EADV Congress
10 Sep 2022 06:00:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
06 Sep 2022 07:00:04 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present Data at the 31st EADV Congress and Provides Update on DesCAARTes™ Trial
29 Aug 2022 12:58:30 By Nasdaq GlobeNewswire
-
Cabaletta Bio Reports Second Quarter 2022 Financial Results and Provides Business Update
11 Aug 2022 06:00:01 By Nasdaq GlobeNewswire
-
18 May 2022 06:00:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the H.C. Wainwright Global Investment Conference
17 May 2022 07:00:04 By Nasdaq GlobeNewswire
-
Cabaletta Bio Reports First Quarter 2022 Financial Results and Provides Business Update
12 May 2022 06:00:02 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 21st Annual Needham Virtual Healthcare Conference
06 Apr 2022 07:00:01 By Nasdaq GlobeNewswire
-
17 Mar 2022 06:00:01 By Nasdaq GlobeNewswire
-
U.S. Food and Drug Administration Grants Cabaletta Bio Fast Track Designation for MuSK-CAART
01 Mar 2022 07:00:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in the Cowen Virtual 42nd Annual Health Care Conference
28 Feb 2022 07:00:02 By Nasdaq GlobeNewswire
-
11 Jan 2022 07:00:02 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference
10 Jan 2022 07:00:04 By Nasdaq GlobeNewswire